Morgan Stanley Call 130 RCL 20.12.../ DE000MG27C21 /
13/06/2024 18:16:05 | Diferencia- | Bid8:39:20 | Ask8:39:20 | Subyacente | Precio de ejercicio | Fecha de expiración | Tipo de opción |
---|---|---|---|---|---|---|---|
3.05EUR | - | 3.14 Volumen de oferta: 1,000 |
3.20 Tamaño/ Volumen/ Formato de Ask: 1,000 |
Royal Caribbean Grou... | 130.00 USD | 20/12/2024 | Call |
GlobeNewswire
9:01
Editas Medicine Reports New Safety and Efficacy Data from the RUBY Trial of Reni-cel in 18 Patients ...
GlobeNewswire
9:00
Beam Therapeutics Reports Data Highlighting Optimized Manufacturing Process for BEAM-101, an Investi...
GlobeNewswire
9:00
Editas Medicine Announces New Safety and Efficacy Data from the EdiTHAL Trial of Reni-cel in 7 Patie...
GlobeNewswire
9:00
Samsung Bioepis Presents Post-hoc Analysis of Phase 3 Study for EPYSQLI™ (SB12; Eculizumab Biosimila...
GlobeNewswire
8:00
Cabaletta Bio Reports Positive Initial Clinical Data from Phase 1/2 RESET-Myositis™ and RESET-SLE™ T...
GlobeNewswire
7:00
Molecular Partners Presents Positive Preclinical Data for First Switch-DARPin Candidate MP0621 at EH...
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página